Literature DB >> 29978446

Sodium removal by peritoneal dialysis: a systematic review and meta-analysis.

Silvio Borrelli1, Vincenzo La Milia2, Luca De Nicola3, Gianfranca Cabiddu4, Roberto Russo5, Michele Provenzano3, Roberto Minutolo3, Giuseppe Conte3, Carlo Garofalo3.   

Abstract

Achievement of sodium and fluid balance is considered a major determinant of dialysis adequacy in peritoneal dialysis (PD). However, the contribution of different PD modalities to dialytic sodium removal (DSR) remains ill-defined. We performed a systematic review and meta-analysis to compare DSR by manual (continuous ambulatory PD, CAPD) versus automated PD (APD). Alternative PD strategies to remove sodium were also analyzed. Seven cohort studies, including 683 patients, 406 in CAPD and 277 in APD, were meta-analyzed out of the 30 studies selected based on DSR data availability. Overall, the unstandardized mean difference between CAPD and APD was significant [- 56 mmol/day (95% CI - 106, - 6), p = 0.027]. Heterogeneity was high (I2 87.2%; p < 0.001). Meta-regression showed a strict correlation of DSR difference with creatinine dialysate/plasma ratio (D/P) (p = 0.04). DSR was significantly lower in APD than CAPD [86.2 (57.3-115.1) vs. 141.3 (107.6-174.9) mmol/day, p = 0.015]. Conversely, ultrafiltration (UF) did not differ [1122.6 (891.2-1354.0) in CAPD and 893.6 (823.0-964.2) ml/day in APD, p = 0.064]. A very strong correlation between DSR and achieved UF was found in CAPD (R = 0.94; p < 0001) while no relationship was detected in APD (R = - 0.07; p = 0.85). CAPD allows a higher DSR than APD, even though UF is not different. APD removes more water than sodium; therefore, DSR should be measured rather than estimated from the achieved UF. The difference in DSR between the two modalities decreases in high transporters. Novel strategies proposed to increase DSR, e.g. lower sodium dialysate or adapted-APD, are promising, but ad hoc studies are necessary.

Entities:  

Keywords:  Peritoneal dialysis; Sodium removal; Ultrafiltration

Mesh:

Year:  2018        PMID: 29978446     DOI: 10.1007/s40620-018-0507-1

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  58 in total

1.  Tidal peritoneal dialysis for home-treated patients: should it be preferred?

Authors:  A Vychytil; T Lilaj; B Schneider; W H Hörl; M Haag-Weber
Journal:  Am J Kidney Dis       Date:  1999-02       Impact factor: 8.860

Review 2.  Evaluation and management of ultrafiltration problems in peritoneal dialysis. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis.

Authors:  S Mujais; K Nolph; R Gokal; P Blake; J Burkart; G Coles; Y Kawaguchi; H Kawanishi; S Korbet; R Krediet; B Lindholm; D Oreopoulos; B Rippe; R Selgas
Journal:  Perit Dial Int       Date:  2000       Impact factor: 1.756

3.  Solute kinetics in automated peritoneal dialysis.

Authors:  G Amici
Journal:  Perit Dial Int       Date:  2000       Impact factor: 1.756

Review 4.  Sodium balance in automated peritoneal dialysis.

Authors:  D G Struijk; R T Krediet
Journal:  Perit Dial Int       Date:  2000       Impact factor: 1.756

5.  Effect of fluid and sodium removal on mortality in peritoneal dialysis patients.

Authors:  K Ateş; G Nergizoğlu; K Keven; A Sen; S Kutlay; S Ertürk; N Duman; O Karatan; A E Ertuğ
Journal:  Kidney Int       Date:  2001-08       Impact factor: 10.612

6.  Spurious estimations of sodium removal during CAPD when [Na](+) is measured by Na electrode methodology.

Authors:  V La Milia; S Di Filippo; M Crepaldi; S Andrulli; P Marai; G Bacchini; L Del Vecchio; F Locatelli
Journal:  Kidney Int       Date:  2000-11       Impact factor: 10.612

Review 7.  Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.

Authors:  D F Stroup; J A Berlin; S C Morton; I Olkin; G D Williamson; D Rennie; D Moher; B J Becker; T A Sipe; S B Thacker
Journal:  JAMA       Date:  2000-04-19       Impact factor: 56.272

8.  What is the optimal frequency of cycling in automated peritoneal dialysis?

Authors:  R A Perez; P G Blake; S McMurray; L Mupas; D G Oreopoulos
Journal:  Perit Dial Int       Date:  2000 Sep-Oct       Impact factor: 1.756

9.  Long-term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients.

Authors:  G Enia; F Mallamaci; F A Benedetto; V Panuccio; S Parlongo; S Cutrupi; G Giacone; E Cottini; G Tripepi; L S Malatino; C Zoccali
Journal:  Nephrol Dial Transplant       Date:  2001-07       Impact factor: 5.992

10.  Peritoneal sodium mass removal in continuous ambulatory peritoneal dialysis and automated peritoneal dialysis: influence on blood pressure control.

Authors:  O Ortega; P Gallar; A Carreño; M Gutierrez; I Rodriguez; A Oliet; A Vigil; E Gimenez
Journal:  Am J Nephrol       Date:  2001 May-Jun       Impact factor: 3.754

View more
  11 in total

Review 1.  Sodium toxicity in peritoneal dialysis: mechanisms and "solutions".

Authors:  Silvio Borrelli; Luca De Nicola; Roberto Minutolo; Alessandra Perna; Michele Provenzano; Gennaro Argentino; Gianfranca Cabiddu; Roberto Russo; Vincenzo La Milia; Toni De Stefano; Giuseppe Conte; Carlo Garofalo
Journal:  J Nephrol       Date:  2019-11-16       Impact factor: 3.902

2.  Characterization of sodium removal to ultrafiltration volume in a peritoneal dialysis outpatient cohort.

Authors:  David A Jaques; Andrew Davenport
Journal:  Clin Kidney J       Date:  2020-04-06

3.  Mild sodium reduction in peritoneal dialysis solution improves hypertension in end stage kidney disease: a case-report study.

Authors:  Luigi Vecchi; Mario Bonomini; Roberto Palumbo; Arduino Arduini; Silvio Borrelli
Journal:  BMC Nephrol       Date:  2021-05-08       Impact factor: 2.388

4.  Optimized vs. Standard Automated Peritoneal Dialysis Regimens (OptiStAR): study protocol for a randomized controlled crossover trial.

Authors:  Karin Bergling; Javier de Arteaga; Fabián Ledesma; Carl Mikael Öberg
Journal:  Pilot Feasibility Stud       Date:  2020-06-10

Review 5.  Sodium Intake and Chronic Kidney Disease.

Authors:  Silvio Borrelli; Michele Provenzano; Ida Gagliardi; Ashour Michael; Maria Elena Liberti; Luca De Nicola; Giuseppe Conte; Carlo Garofalo; Michele Andreucci
Journal:  Int J Mol Sci       Date:  2020-07-03       Impact factor: 5.923

6.  Ultrasonography of Quadriceps Femoris Muscle and Subcutaneous Fat Tissue and Body Composition by BIVA in Chronic Dialysis Patients.

Authors:  Yuri Battaglia; Ines Ullo; Sara Massarenti; Pasquale Esposito; Michele Prencipe; Giovanni Ciancio; Michele Provenzano; Fulvio Fiorini; Michele Andreucci; Alda Storari; Alice Sabatino; Enrico Fiaccadori; Antonio Granata
Journal:  Nutrients       Date:  2020-05-12       Impact factor: 5.717

7.  Peritoneal dialysis care during the COVID-19 pandemic, Thailand.

Authors:  Talerngsak Kanjanabuch; Krit Pongpirul
Journal:  Bull World Health Organ       Date:  2021-11-04       Impact factor: 9.408

Review 8.  The Role of Prognostic and Predictive Biomarkers for Assessing Cardiovascular Risk in Chronic Kidney Disease Patients.

Authors:  Michele Provenzano; Michele Andreucci; Luca De Nicola; Carlo Garofalo; Yuri Battaglia; Silvio Borrelli; Ida Gagliardi; Teresa Faga; Ashour Michael; Pasquale Mastroroberto; Giuseppe Filiberto Serraino; Noemi Licastro; Nicola Ielapi; Raffaele Serra
Journal:  Biomed Res Int       Date:  2020-10-08       Impact factor: 3.411

Review 9.  APD or CAPD: one glove does not fit all.

Authors:  Athanasios Roumeliotis; Stefanos Roumeliotis; Konstantinos Leivaditis; Marios Salmas; Theodoros Eleftheriadis; Vassilios Liakopoulos
Journal:  Int Urol Nephrol       Date:  2020-10-13       Impact factor: 2.370

Review 10.  The osmo-metabolic approach: a novel and tantalizing glucose-sparing strategy in peritoneal dialysis.

Authors:  Mario Bonomini; Victor Zammit; José C Divino-Filho; Simon J Davies; Lorenzo Di Liberato; Arduino Arduini; Mark Lambie
Journal:  J Nephrol       Date:  2020-08-07       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.